Self-guided online therapy for patients with anxiety disorders
The Effect of a Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders
This study tests whether a self-guided online therapy program can help people with anxiety feel better while they wait for in-person therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 1 site (Berlin) |
| Trial ID | NCT04793828 on ClinicalTrials.gov |
What this trial studies
This project investigates the effects of a self-guided, internet-based cognitive behavioral therapy program called Velibra for patients with anxiety disorders who are on a waitlist for face-to-face therapy. Participants will complete a pre-treatment assessment and then access Velibra at their own pace, with support from study personnel during four assessment points. The study aims to evaluate both the effectiveness of the program and its acceptability, particularly observing changes after the initial modules. The goal is to provide an alternative therapeutic option while patients await traditional psychotherapy.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with panic disorder (with or without agoraphobia), social anxiety disorder, or generalized anxiety disorder who can understand German and have internet access.
Not a fit: Patients with severe mental health comorbidities or acute suicidality may not benefit from this self-guided intervention.
Why it matters
Potential benefit: If successful, this intervention could provide timely relief and coping strategies for patients with anxiety disorders while they wait for in-person therapy.
How similar studies have performed: Other studies have shown success with internet-based cognitive behavioral therapy approaches, indicating potential for this method.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of panic disorder with or without agoraphobia, social anxiety disorder, or generalized anxiety disorder * Knowledge of German that is sufficient for engaging with the treatment and responding to the questionnaires * Written informed consent * Internet access Exclusion Criteria: * Diagnoses of severe mental comorbidities (e.g., schizophrenia, severe major depression, borderline personality disorder) * Acute suicidality * Started or changed anxiolytic pharmacotherapy recently (currently or in the past four weeks)
Where this trial is running
Berlin
- Department of Psychiatry and Psychotherapy, Charité Campus Mitte - Universitätsmedizin Berlin — Berlin, Germany (Recruiting)
Study contacts
- Principal investigator: Lena Pyrkosch, Dipl.-Psych. — Department of Psychiatry and Psychotherapy, Charité Campus Mitte - Universitätsmedizin Berlin
- Study coordinator: Anna Wehrheim, M.Sc.-Psych.
- Email: anna.wehrheim@charite.de
- Phone: +49 30 450 517 017
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.